Penn State Hershey Cancer Institute Research
Welcome to Penn State Hershey Cancer Institute
Intellect and discovery characterize growth at the Penn State Hershey Cancer Institute. We continue to emphasize our state-of-the-art interdisciplinary patient care, in which medical, surgical and radiation oncologists jointly determine the best therapeutic course for each patient. We also focus our attention on becoming designated by the National Cancer Institute (NCI). Among other strengths, the Cancer Institute's emphasis on rural, underserved populations is a focus of the CCSG application. Many of these efforts are conducted through the Appalachian Cancer Network by volunteers throughout Pennsylvania who provide education and screening services, as well as behavioral interventions, to reduce cancer risk. Our free-standing facility, which opened June 2009, was designed to reinforce our concept of a community of individuals devoted to providing comprehensive cancer care and finding a cure for cancer.
The Cancer Institute's four scientific programs:
- Cancer Virology and Immunology
- Mechanisms of Carcinogenesis and Chemoprevention
- Cancer Control and Population Health
- Experimental Therapeutics
The scientists in the Cancer Control and Population Health and the Mechanisms of Carcinogenesis and Chemoprevention Programs continue collaborative work on two major grants examining the role of tobacco in leading to cancer. In the Experimental Therapeutics Program, our scientists have been awarded several grants from NCI in the area of nanotechnology. These projects, developed with leading researchers at University Park, are aimed at delivering new cancer treatments to individual cancer cells. Through our network of local hospitals throughout central and northeastern Pennsylvania, the Penn State Hershey Cancer Institute brings research to patients in a growing number of communities. Click here for a list of our partners and affiliates.
We continue to expand our research programs. PSHCI now has 143 investigators from 25 academic departments in six colleges located at the Hershey and University Park campuses. Over the past five years, our NCI funding has increased by 16% with a 22% increase in the past 3 years. This is quite impressive given the funding crisis at the NIH. We are making similar strides in the area of clinical trials. In the past year, 18% of our new cancer patients were enrolled on a therapeutic or prevention trial.
The Medical Minute: Children and hot cars a cause for deadly concern
Nearly 700 children have lost their lives over the last 20 years in the United States as a result of being left in or playing in a hot car. At last count, the total in the U.S. this year is 18. National Heat Stroke Prevention Day is July 31.More...
Crafting and racing Pinewood Derby cars at the Children’s Hospital
Patients at Penn State Hershey Children’s Hospital and their families got to try their hand at crafting Pinewood Derby cars. The Austin Hatcher Foundation for Pediatric Cancer, or AHF, brought Pinewood Derby kits to the hospital where children personalized their cars with stickers, markers and other materials.More...
Parent to present at RQA Lecture on Aug. 13
The next Research Quality Assurance Lecture at Penn State Hershey will be presented by Dr. Leslie Parent, professor of medicine and microbiology and immunology; chief, Division of Infectious Diseases and Epidemiology; and co-director of the M.D./Ph.D. Program. She will present “Studying Viruses Using Microscopic Imaging, One Cell at a Time.”More...
ACLS experienced provider course planned at Penn State Hershey
Individuals who hold current ACLS certification and who work in acute care settings where they function as part of a code team on a regular basis may choose to renew their ACLS certification by attending the new ACLS EP Course at Penn State Hershey.More...